Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-99.86	0.15	110.88
Graham Fair Price	41.42	1.77	1.25
PEG	-92.76	-0.01	0.16
Price/Book	-4.06	0.20	0.21
Price/Cash Flow	-100.00	-33.59	0.00
Prices/Earnings	52.03	-1.14	-2.38
Price/Sales	-58.95	2.15	5.24
Price/FCF	-100.00	-33.59	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-16.03	0.84	1.00
Operating Margin	18.20	0.22	-0.19
ROA	-100.00	< 0.005	< 0.005
ROE	-0.02	-0.04	-100.00
ROIC	-0.02	0.04	117.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.27	3.76	195.74
EPS QOQ	0.15	-1.00	562.32
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	-0.70	1.34	90.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	1322.48	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.21	100.00
Quick Ratio	0.00	0.88	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.79	1.79	< 0.005
Cash	0.82	3.22	290.05
Capex	0.00	< 0.005	-100.00
Free Cash Flow	0.00	-0.01	-100.00
Revenue	0.07	0.16	133.75
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.00	1.24	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	201.13	-6.28	-96.88
Naive Interpretation	Member

06 - Financial Health · Weak

Rating